The commercialization of cannabis has increased its use across society, including within faith communities, creating significant implications for psychiatric care. Many patients and clinicians remain underinformed about the potential risks associated with cannabis use, often influenced by misconceptions regarding “medical” cannabis. Contrary to popular belief, the approval and prescription of cannabis lack consistent, evidence-based standards and vary significantly across states. This workshop aimed for psychologists, licensed mental health professionals, medical personnel, and ministry leaders dispels the prevalent myths, elucidate the process of obtaining “medical” cannabis, and emphasize the associated risks, particularly for vulnerable groups such as adolescents and pregnant women. Conditions like anxiety, insomnia, chronic pain, and PTSD are frequently cited for cannabis use, yet clinicians must rely on evidence-based guidelines rather than public opinion or anecdotal claims. By fostering informed decision-making, this workshop seeks to equip participants with the knowledge necessary to navigate cannabis-related issues in psychiatric practice effectively.
116 | Cannabis Use & Clinical Practice: Realities, Myths and Implications
PRESENTERS
Linda Mintle, Ph.D.
CE CREDITS
1.25
Approved For CE
APA, ASWB, NBCC, NAADAC, IBCC, AMA PRA Category 1 Credits, AOA Category 2A Credits, Georgia Nurses Association, AAFP , Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling
Approved For CME/CEU
LEVEL
Intermediate
Summary
Learning Objectives
1 Identify common myths about cannabis held by patients and clinicians
2 Recognize the risks of cannabis use, including cannabis hyperemesis syndrome, addiction, and its impact on clinical conditions (e.g., anxiety, mood disorders, PTSD).
3 Explain "medical" marijuana and the process for obtaining it along with a theological perspective on cannabis use for Christian clients.